Board of Directors

DR ANDREW WALKER B. Med. B. Med. Sci. (Hons) MBA FICS
Chairman

Andrew is the Chairman of Aspen Medical Pty Ltd and CEO of Matrix Healthcare Pty Ltd both Australian-based companies with national and international experience in the delivery of health care solutions. This delivery ranges from Primary Care services through to complete Surgical Solutions in both First and Third World settings. Over the last 12 years, he has developed and commercialised a range of successful medical and health-related businesses, including the Australian Skin Cancer Clinics and Combined Pathology.

Andrew has two medical degrees from Newcastle University and has won places at both Harvard and Oxford Universities. He is a Fellow of the International College of Surgeons. He has also been awarded a MBA from the Melbourne Business School. Prior to beginning his business career, Andrew was a platoon commander in Australia’s Parachute Battalion (3 RAR para). He is a non-executive director of Resonance Healthcare Ltd and Ritract Ltd, both ASX listed companies.

MR HARRY KARELIS B.Sc (Hons), MBA
Non-executive Director

Harry Karelis is the Managing Director of Biotech Capital Ltd. Harry graduated from The University of Western Australia with Bachelors and Honours in Science majoring in Biochemistry and Microbiology as well as a Masters in Business Administration.

He is an Associate of the Securities Institute of Australia, a Fellow of the Australian Institute of Company Directors and has qualified as a Chartered Financial Analyst (CFA) from the Association of Investment Management and Research (AIMR) in the United States.

He has a background in financial analysis and funds management both in Australia and overseas including several years working in Singapore where he was employed by a major international bank.

MR MARK FELDSCHUH B.Pharm MPS FAIPM
Non-Executive Director

Mark, a registered pharmacist, is currently the Vice President of the Pharmaceutical Society of Australia (Victorian branch) and chairs the Professional Development Committee. He is also a National Councillor (Director) of the Pharmaceutical Society. He is a Fellow of the Australian Institute of Pharmacy Management and a member of the Pharmacy Guild of Australia, the International Association of Compounding Pharmacists and the Pharmacy Advisory Group of the National Asthma Council. Mark has owned the Belvedere Park Pharmacy in Melbourne since 1975.

DR KAMAL K SHARMA B.Eng (Chem), PhD
Deputy Chairman and Non-executive Director

Dr Kamal K Sharma is the managing director of Lupin Pharmaceuticals. He is a graduate in chemical engineering from the Indian institute of Technology (IIT), Kanpur, with a post-graduate diploma in industrial management from Jamnalal Bajaj Institute of management Studies, Mumbai, and a Ph.D in economics from IIT, Mumbai. He has also completed an advanced management program from Harvard Business School, Boston.

In a career spanning more than three decades, Dr. Sharma has held a range of senior management positions managing projects, corporate development and general management in the pharmaceuticals and chemicals industries.

SOFIA MUMTAZ
Non-executive Director

Dr Mumtaz is the Senior Vice President Intellectual Property for Lupin Limited based in Mumbai, India. Dr Mumtaz has championed numerous successful patent litigation campaigns against innovator companies in the USA.

VINOD DHAWAN
Non-executive Director

Mr Dhawan is the President of Business Development and President of all markets outside India, USA and EU for Lupin Limited.

MR LESLIE WEBB LLB
Deputy Chairman, Non-Executive Director

Les is a Barrister of the Supreme Court of New South Wales, Barrister and Solicitor of the Supreme Court of Victoria and Barrister and Solicitor of the High Court of Australia. He has consulted extensively to both publicly listed and unlisted public companies in the information technology and biotechnology industries on corporate and financial planning, intellectual property, corporate governance and strategic planning issues. In his role as a consultant he has been actively involved in advising on the globalisation of Australian companies.
Les was previously a director of ASX listed biotechnology company Gradipore (now Life Therapeutics Ltd) and is currently non-executive Chairman of Stem Cell Sciences Ltd in Australia and a nonexecutive Director of Stem Cell Sciences plc listed on the London Alternative Investment Market. Les also sits on the boards as a non-executive of Health Insurance intermediary iSelect and telecommunications company Mobileselect.

MR GAVIN UPITER BSc Eng (Mech.)
Managing Director

Gavin Upiter is the Managing Director of Generic Health. He founded the company in 2004 with a vision to revolutionise the generic drugs market in Australia. Generic Health was the pioneer in offering unbundled generics and transparent pricing to the pharmaceutical industry. Under Gavin's leadership, the company has grown from a groundbreaking idea into the fastest growing business in the generics market.

Prior to launching Generic Health, Gavin, a veteran in the pharmaceutical industry, spent over 11 years at Bristol-Myers Squibb. During his time there , Gavin was responsible for all manufacturing activities fro products which accounted for over AU$500 million in sales across 30 countries. Gavin was on of two individuals in Australia nominated as the representative for the pharmaceutical manufacturing licence held by Bristol-Myers Squibb Australia. As such, the founder was accountable fro ensuring compliance with Good Manufacturing Practice and regulatory standards across the company.

Gavin is a qualified engineer and holds a Bachelor of Science in Engineering (mechanical) from The University of the Witwatersrand, Johannesburg.